# Prophylaxis of Post-ERCP Acute Pancreatitis

> **NCT05381428** · PHASE3 · COMPLETED · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 184 (actual)

## Conditions studied

- Pancreatitis, Acute

## Interventions

- **DRUG:** Indomethacin suppository
- **COMBINATION_PRODUCT:** Indomethacin suppository and high-flow lactated ringer infusion combination

## Key facts

- **NCT ID:** NCT05381428
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-13
- **Primary completion:** 2024-10-12
- **Final completion:** 2024-10-12
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05381428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05381428, "Prophylaxis of Post-ERCP Acute Pancreatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05381428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*